Nuerepa Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.89 Cr
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
About Nuerepa Biotechnology
Nuerepa Biotechnology Private Limited (NBPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 15 December 2020 (Four years and two months 13 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hyungjin Shin, Dongwon Kim, Sudha Kumari, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909DL2020FTC374559
- Company No.
374559
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
15 Dec 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Nuerepa Biotechnology?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hyungjin Shin  | Director | 15-Dec-2020 | Current |
| Dongwon Kim | Director | 26-May-2023 | Current |
Sudha Kumari  | Director | 15-Dec-2020 | Current |
| Young Kim | Director | 06-Apr-2022 | Current |
Financial Performance of Nuerepa Biotechnology.
Nuerepa Biotechnology Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nuerepa Biotechnology?
In 2022, Nuerepa Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nuerepa Biotechnology?
Nuerepa Biotechnology has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuerepa Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuerepa Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.